Videos

Tricia Strusowski, MS, RN, Oncology Solutions, discusses the importance of the nurse navigator role, especially in community oncology settings, at the 2017 ACCC Cancerscape meeting.

Patrick Spencer, RN, OCN provides important points to cover when counseling a patient with multiple myeloma receiving treatment with daratumumab.

Sandra Allen-Bard discusses her passion for advocacy involvement with the Leukemia & Lymphoma Society.

Ragini Kudchadkar, MD, explains what nurses should keep in mind when treating patients with basal cell carcinoma.

Robert Andtbacka, MD, CM, notes the importance of treating the patient’s emotional needs, as well as the needs of the patient’s family.

Richard Carvajal, MD, discusses the importance of a multidisciplinary approach when monitoring patients for immunotherapy toxicities.

Alyson Moadel-Robblee, PhD, discusses what keeps male patients with prostate cancer from seeking out counseling and therapy.

Partow Kebriaei, MD, from MD Anderson Cancer Center, discusses how nurses can monitor patients for cytokine release syndrome.

Alix Beaupierre, RN, BSN, OCN, Moffitt Cancer Center, explains the patient education program created for a recent CAR T-cell therapy clinical trial.

Dr. Robert Andtbacka explains the important role the nurse plays before and after surgery for melanoma.

Morganna Freeman discusses how nurses can prepare for side effect management in clinical trials.

Ragini Kudchadkar, MD, explains how nurses can communication with patients with merkel and basal cell carcinoma, who may not have access to the internet.

Richard Carvajal, MD, discusses how to make decisions regarding the dosing limits of immunotherapy agents.

Keith Stewart, MB, ChB from Mayo Clinic in Scottsdale, discusses the use of monoclonal antibodies for treatment in multiple myeloma.

Claire Friedman discusses the factors clinicians should consider when determining an immunotherapy treatment plan for older patients.

Supriya Mohile discusses the disparity that can exist between patients in clinical trials and patients that providers experience in the real world.

Keith Stewart, MB, ChB from Mayo Clinic in Scottsdale, discusses the use of monoclonal antibodies for treatment in multiple myeloma.

Elizabeth Repasky, PhD, discusses the effect that lifestyle factors can have on immune reponses in patients with cancer.

Sam Smith, PhD, discusses the relationship between menopausal symptoms and non-adherence in patients receiving tamoxifen.

Krista Qualmann discusses hereditary cancer syndromes.

Beth Sandy discusses the use of anti-psychotoci agent, olanzapine, when managing chemotherapy-induced nausea and vomiting (CINV).

Tara Sanft discusses how nurses can help support a patient with breast cancer who fears recurrence.

Jeannine Brant discusses factors that can influence a patient's perception of malignant pain.

Laura Wood on collaboration between departments when treating patients with cancer who are receiving immunotherapy treatments.

Debu Tripathy discuss how to encouragecompliance and adherence for patients with breast cancer who are receiving hormone therapy.